Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Hormonal imbalances, including high prolactin and thyroid issues, contribute to hair growth problems in women.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Elderly patients with frailty should be checked for hypopituitarism, as treatment can greatly improve their health and lifespan.

Specific tests may help diagnose alopecia, but their treatment impact is unclear.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Taking a daily multivitamin may be enough to promote hair growth in people with alopecia.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

New understanding and treatments for hair loss are improving, but more research is needed.

Combining lab tests with clinical observations is crucial for diagnosing hormonal skin issues in dogs.

Surgical removal of an adrenal tumor resolved hormonal issues in a young woman.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Microbes in the small intestine may cause Post-Finasteride Syndrome symptoms.

Microbes in the small intestine may cause Post-Finasteride Syndrome symptoms.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.